Telehealth and remote patient monitoring providers are being offered free or below-cost RPM devices by vendors, device manufacturers, and management companies looking to place equipment ahead of billing. That arrangement is remuneration under the federal Anti-Kickback Statute, and if the device is furnished to a Medicare or Medicaid beneficiary rather than the practice, it also raises the Beneficiary Inducement Civil Monetary Penalty law. The Office of Inspector General has flagged both patterns directly: a July 2022 Special Fraud Alert on telemedicine arrangements and a November 2023 consumer alert on remote patient monitoring schemes, each built on the same fact pattern of free equipment tied to ongoing billing.
Device Supply as Remuneration Under the Anti-Kickback Statute
The Anti-Kickback Statute, codified at 42 U.S.C. Section 1320a-7b(b), prohibits knowingly offering, paying, soliciting, or receiving anything of value to induce referrals or generate business payable under a federal health care program. A device supplied at no charge or below its fair market rental or purchase value is remuneration under that statute regardless of the label the vendor puts on the arrangement, loaner, trial unit, or included service. In its July 20, 2022 Special Fraud Alert on telemedicine arrangements, OIG identified compensation tied to the volume of orders generated and marketing built around free or low out-of-pocket items as suspect characteristics that regulators use to infer the required intent to induce.
Free Devices to Patients and the Beneficiary Inducement CMP
A separate statute governs items given directly to beneficiaries. The Beneficiary Inducement CMP at 42 U.S.C. Section 1320a-7a(a)(5) penalizes offering a Medicare or Medicaid beneficiary something of value that the offeror knows or should know is likely to influence the beneficiary's choice of provider. OIG's November 22, 2023 consumer alert on RPM fraud warned beneficiaries to be wary of unsolicited offers of free monitoring equipment, noting that companies making those offers frequently bill Medicare for setup, education, and monitoring the patient never actually receives. A loaner device given to keep a patient engaged with a particular prescriber fits squarely inside the conduct the CMP was written to reach.
The Narrow Exception That Can Cover a Loaner Device
A device given to a patient is not automatically unlawful. OIG's Advisory Opinion 19-02 (March 4, 2019) approved a manufacturer's loan of a limited-function device to track medication adherence under the CMP's promotes access to care exception, codified at 42 CFR Section 1003.110. That exception requires the item to be unlikely to interfere with clinical decision-making, unlikely to increase utilization or cost to federal programs, and free of patient safety or quality-of-care concerns. OIG's favorable view turned on the device's narrow function, no internet browser, no camera, no ability to add other applications, and on the absence of any prescriber incentive tied to the loan. A general-purpose RPM device with broader functionality, or one advertised to attract patients rather than support a specific ordered course of monitoring, does not fit the same analysis.
Vendor Arrangements That Draw Scrutiny
Kickback exposure and billing exposure travel together in RPM device arrangements. A vendor that supplies equipment for exclusive use, or a management fee tied to the volume of readings billed, invites a Unified Program Integrity Contractor or Medicare Administrative Contractor to pull the same file for a documentation review and an OIG referral. A recoupment demand on the underlying claims is rarely the only consequence once a device supply arrangement looks like remuneration; the same file can support a parallel Anti-Kickback Statute theory built on the arrangement itself.
A device supplied for free or below its fair market value is remuneration whether the vendor calls it a loaner, a trial unit, or a value-added service, and the analysis does not change based on the label.
Why Early Legal Counsel Is Critical
It is critical that telehealth and RPM providers promptly retain experienced healthcare defense counsel before entering a device supply arrangement, and immediately upon receiving a subpoena, audit request, or OIG inquiry tied to one already in place. Early legal intervention can structure the arrangement to fit an available exception, document fair market value, avoid inadvertent admissions during a records exchange, and allow counsel to communicate with investigators on the provider's behalf. Delaying legal review until after a contract is signed narrows the options considerably.
How Health Law Alliance Can Help
Health Law Alliance has handled 5,000+ matters across healthcare regulatory and audit defense over 25+ years, including Anti-Kickback Statute, beneficiary inducement, and False Claims Act exposure tied to telehealth and remote patient monitoring device arrangements. If your practice is negotiating a vendor device supply agreement, or has received an inquiry about one already signed, contact Health Law Alliance's telehealth and telemedicine attorneys for a free, confidential consultation.
